Παρακολούθηση
Christos Gioumouxouzis
Christos Gioumouxouzis
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα pharm.auth.gr
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery
CI Gioumouxouzis, A Baklavaridis, OL Katsamenis, CK Markopoulou, ...
European Journal of Pharmaceutical Sciences 120, 40-52, 2018
2022018
3D printed oral solid dosage forms containing hydrochlorothiazide for controlled drug delivery
CI Gioumouxouzis, OL Katsamenis, N Bouropoulos, DG Fatouros
Journal of Drug Delivery Science and Technology 40, 164-171, 2017
1592017
Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies
CI Gioumouxouzis, C Karavasili, DG Fatouros
Drug discovery today 24 (2), 636-643, 2019
1262019
Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients
CI Gioumouxouzis, E Tzimtzimis, OL Katsamenis, A Dourou, ...
European Journal of Pharmaceutical Sciences 143, 105176, 2020
842020
Controlled release of 5-fluorouracil from alginate beads encapsulated in 3D printed pH-responsive solid dosage forms
CI Gioumouxouzis, AT Chatzitaki, C Karavasili, OL Katsamenis, D Tzetzis, ...
Aaps Pharmscitech 19, 3362-3375, 2018
682018
Mucosal drug delivery and 3D printing technologies: A focus on special patient populations
C Karavasili, GK Eleftheriadis, C Gioumouxouzis, EG Andriotis, ...
Advanced Drug Delivery Reviews 176, 113858, 2021
472021
The advent of a new era in digital healthcare: a role for 3D printing technologies in drug manufacturing?
II Andreadis, CI Gioumouxouzis, GK Eleftheriadis, DG Fatouros
Pharmaceutics 14 (3), 609, 2022
422022
Quality control evaluation of paediatric chocolate-based dosage forms: 3D printing vs mold-casting method
K Chachlioutaki, C Karavasili, EE Mavrokefalou, CI Gioumouxouzis, ...
International journal of pharmaceutics 624, 121991, 2022
192022
Negative electrospray ionization mode in mass spectrometry: a new perspective via modeling
CI Gioumouxouzis, MG Kouskoura, CK Markopoulou
Journal of Chromatography B 998, 97-105, 2015
182015
X‐ray microfocus computed tomography: a powerful tool for structural and functional characterisation of 3D printed dosage forms
CI Gioumouxouzis, OL Katsamenis, DG Fatouros
Journal of Microscopy 277 (3), 135-139, 2020
72020
Emerging 3D printing technologies to develop novel pharmaceutical formulations
CI Gioumouxouzis1, GK Eleftheriadis1, DG Fatouros1
3D and 4D Printing in Biomedical Applications: Process Engineering and …, 2019
52019
A floating 3D printed polypill formulation for the coadministration and sustained release of antihypertensive drugs
P Zgouro, OL Katsamenis, T Moschakis, GK Eleftheriadis, AS Kyriakidis, ...
International Journal of Pharmaceutics 655, 124058, 2024
2024
Small patients, big challenges: navigating pediatric drug manipulations to prevent medication errors-a comprehensive review
K Chachlioutaki, C Gioumouxouzis, C Karavasili, DG Fatouros
Expert Opinion on Drug Delivery 20 (11), 1489-1509, 2023
2023
Correction: Andreadis et al. The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing? Pharmaceutics 2022, 14, 609
II Andreadis, CI Gioumouxouzis, GK Eleftheriadis, DG Fatouros
Pharmaceutics 14 (12), 2782, 2022
2022
Short Lecture “New 3D-printed oral dosage forms”
C Karavasili, C Gioumouxouzis, G Eleftheriadis, D Fatouros
Planta Medica 88 (15), SL-FOR04, 2022
2022
3PC-068 3D printing of elaborate pharmaceutical formulations for personalised therapy
C Gioumouxouzis, O Katsamenis, D Fatouros
Eur J Hosp Pharm 26 (Suppl 1), A67-A68, 2019
2019
FABRICATION OF INNOVATIVE DOSAGE FORMS BY MEANS OF 2D/3D PRINTING
CI Gioumouxouzis, EG Andriotis, DG Fatouros
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–17